Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter

Carlo Senore; Andrea Ederle; Giovanni DePretis; Corrado Magnani; Debora Canuti; Silvia Deandrea; Manuel Zorzi; Alessandra Barca; Piero Bestagini; Katia Faitini; Luigi Bisanti; Coralba Casale; Antonio Ferro; Paolo GiorgiRossi; Francesco Quadrino; Giorgia Fiorina; Arianna Capuano; Nereo Segnan; Alberto Fantin

doi:10.1016/j.ypmed.2015.01.005

Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter

Carlo Senore, Andrea Ederle, Giovanni DePretis, Corrado Magnani, Debora Canuti, Silvia Deandrea, Manuel Zorzi, Alessandra Barca, Piero Bestagini, Katia Faitini, Luigi Bisanti, Coralba Casale, Antonio Ferro, Paolo GiorgiRossi, Francesco Quadrino, Giorgia Fiorina, Arianna Capuano, Nereo Segnan, Alberto Fantin

Arcispedale Santa Maria Nuova

Research output: Contribution to journal › Article

Abstract

Aim: To estimate the impact of an advance notification letter on participation in sigmoidoscopy (FS) and fecal immunochemical test (FIT) screening. Methods: Eligible subjects, invited in 3 Italian population based programmes using FS and in 5 using FIT, were randomised (1:1:1), within GP, to: A) standard invitation letter; B) advance notification followed after 1. month by the standard invitation; and C) B. +. indication to contact the general practitioner (GP) to get advice about the decision to be screened. We calculated the 9-month attendance and the incremental cost of each strategy. We conducted a phone survey to assess GP's utilization and predictors of participation. Results: The advance notification was associated with a 20% increase in the attendance among 15,655 people invited for FS (B vs A - RR: 1.17, 95% CI: 1.10-1.25; C vs A - RR: 1.19, 95% CI: 1.12-1.27); the incremental cost ranged between 10 and 9 Euros. Participation in FIT screening (N. = 23,543) was increased only with simple pre-notification (B vs A - RR: 1.06, 95% CI: 1.02-1.10); the incremental cost was 22.5 Euros. GP consultation rate was not increased in group C. Conclusions: An advance notification represents a cost-effective strategy to increase participation in FS screening; its impact on the response to FIT screening was limited.

Original language	English
Pages (from-to)	106-111
Number of pages	6
Journal	Preventive Medicine
Volume	73
DOIs	https://doi.org/10.1016/j.ypmed.2015.01.005
Publication status	Published - Apr 1 2015

Keywords

CRC screening
FIT
Participation
Sigmoidoscopy

ASJC Scopus subject areas

Public Health, Environmental and Occupational Health
Epidemiology
Medicine(all)

Access to Document

10.1016/j.ypmed.2015.01.005

Fingerprint Dive into the research topics of 'Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter'. Together they form a unique fingerprint.

Cite this

Senore, C., Ederle, A., DePretis, G., Magnani, C., Canuti, D., Deandrea, S., Zorzi, M., Barca, A., Bestagini, P., Faitini, K., Bisanti, L., Casale, C., Ferro, A., GiorgiRossi, P., Quadrino, F., Fiorina, G., Capuano, A., Segnan, N., & Fantin, A. (2015). Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter. Preventive Medicine, 73, 106-111. https://doi.org/10.1016/j.ypmed.2015.01.005

Invitation strategies for colorectal cancer screening programmes : The impact of an advance notification letter. / Senore, Carlo; Ederle, Andrea; DePretis, Giovanni; Magnani, Corrado; Canuti, Debora; Deandrea, Silvia; Zorzi, Manuel; Barca, Alessandra; Bestagini, Piero; Faitini, Katia; Bisanti, Luigi; Casale, Coralba; Ferro, Antonio; GiorgiRossi, Paolo; Quadrino, Francesco; Fiorina, Giorgia; Capuano, Arianna; Segnan, Nereo; Fantin, Alberto.

In: Preventive Medicine, Vol. 73, 01.04.2015, p. 106-111.

Research output: Contribution to journal › Article

Senore, C, Ederle, A, DePretis, G, Magnani, C, Canuti, D, Deandrea, S, Zorzi, M, Barca, A, Bestagini, P, Faitini, K, Bisanti, L, Casale, C, Ferro, A, GiorgiRossi, P, Quadrino, F, Fiorina, G, Capuano, A, Segnan, N & Fantin, A 2015, 'Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter', Preventive Medicine, vol. 73, pp. 106-111. https://doi.org/10.1016/j.ypmed.2015.01.005

Senore, Carlo ; Ederle, Andrea ; DePretis, Giovanni ; Magnani, Corrado ; Canuti, Debora ; Deandrea, Silvia ; Zorzi, Manuel ; Barca, Alessandra ; Bestagini, Piero ; Faitini, Katia ; Bisanti, Luigi ; Casale, Coralba ; Ferro, Antonio ; GiorgiRossi, Paolo ; Quadrino, Francesco ; Fiorina, Giorgia ; Capuano, Arianna ; Segnan, Nereo ; Fantin, Alberto. / Invitation strategies for colorectal cancer screening programmes : The impact of an advance notification letter. In: Preventive Medicine. 2015 ; Vol. 73. pp. 106-111.

@article{c9132a32d1b148449af19a9f386fc219,

title = "Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter",

abstract = "Aim: To estimate the impact of an advance notification letter on participation in sigmoidoscopy (FS) and fecal immunochemical test (FIT) screening. Methods: Eligible subjects, invited in 3 Italian population based programmes using FS and in 5 using FIT, were randomised (1:1:1), within GP, to: A) standard invitation letter; B) advance notification followed after 1. month by the standard invitation; and C) B. +. indication to contact the general practitioner (GP) to get advice about the decision to be screened. We calculated the 9-month attendance and the incremental cost of each strategy. We conducted a phone survey to assess GP's utilization and predictors of participation. Results: The advance notification was associated with a 20% increase in the attendance among 15,655 people invited for FS (B vs A - RR: 1.17, 95% CI: 1.10-1.25; C vs A - RR: 1.19, 95% CI: 1.12-1.27); the incremental cost ranged between 10 and 9 Euros. Participation in FIT screening (N. = 23,543) was increased only with simple pre-notification (B vs A - RR: 1.06, 95% CI: 1.02-1.10); the incremental cost was 22.5 Euros. GP consultation rate was not increased in group C. Conclusions: An advance notification represents a cost-effective strategy to increase participation in FS screening; its impact on the response to FIT screening was limited.",

keywords = "CRC screening, FIT, Participation, Sigmoidoscopy",

author = "Carlo Senore and Andrea Ederle and Giovanni DePretis and Corrado Magnani and Debora Canuti and Silvia Deandrea and Manuel Zorzi and Alessandra Barca and Piero Bestagini and Katia Faitini and Luigi Bisanti and Coralba Casale and Antonio Ferro and Paolo GiorgiRossi and Francesco Quadrino and Giorgia Fiorina and Arianna Capuano and Nereo Segnan and Alberto Fantin",

year = "2015",

month = apr,

day = "1",

doi = "10.1016/j.ypmed.2015.01.005",

language = "English",

volume = "73",

pages = "106--111",

journal = "Preventive Medicine",

issn = "0091-7435",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Invitation strategies for colorectal cancer screening programmes

T2 - The impact of an advance notification letter

AU - Senore, Carlo

AU - Ederle, Andrea

AU - DePretis, Giovanni

AU - Magnani, Corrado

AU - Canuti, Debora

AU - Deandrea, Silvia

AU - Zorzi, Manuel

AU - Barca, Alessandra

AU - Bestagini, Piero

AU - Faitini, Katia

AU - Bisanti, Luigi

AU - Casale, Coralba

AU - Ferro, Antonio

AU - GiorgiRossi, Paolo

AU - Quadrino, Francesco

AU - Fiorina, Giorgia

AU - Capuano, Arianna

AU - Segnan, Nereo

AU - Fantin, Alberto

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Aim: To estimate the impact of an advance notification letter on participation in sigmoidoscopy (FS) and fecal immunochemical test (FIT) screening. Methods: Eligible subjects, invited in 3 Italian population based programmes using FS and in 5 using FIT, were randomised (1:1:1), within GP, to: A) standard invitation letter; B) advance notification followed after 1. month by the standard invitation; and C) B. +. indication to contact the general practitioner (GP) to get advice about the decision to be screened. We calculated the 9-month attendance and the incremental cost of each strategy. We conducted a phone survey to assess GP's utilization and predictors of participation. Results: The advance notification was associated with a 20% increase in the attendance among 15,655 people invited for FS (B vs A - RR: 1.17, 95% CI: 1.10-1.25; C vs A - RR: 1.19, 95% CI: 1.12-1.27); the incremental cost ranged between 10 and 9 Euros. Participation in FIT screening (N. = 23,543) was increased only with simple pre-notification (B vs A - RR: 1.06, 95% CI: 1.02-1.10); the incremental cost was 22.5 Euros. GP consultation rate was not increased in group C. Conclusions: An advance notification represents a cost-effective strategy to increase participation in FS screening; its impact on the response to FIT screening was limited.

AB - Aim: To estimate the impact of an advance notification letter on participation in sigmoidoscopy (FS) and fecal immunochemical test (FIT) screening. Methods: Eligible subjects, invited in 3 Italian population based programmes using FS and in 5 using FIT, were randomised (1:1:1), within GP, to: A) standard invitation letter; B) advance notification followed after 1. month by the standard invitation; and C) B. +. indication to contact the general practitioner (GP) to get advice about the decision to be screened. We calculated the 9-month attendance and the incremental cost of each strategy. We conducted a phone survey to assess GP's utilization and predictors of participation. Results: The advance notification was associated with a 20% increase in the attendance among 15,655 people invited for FS (B vs A - RR: 1.17, 95% CI: 1.10-1.25; C vs A - RR: 1.19, 95% CI: 1.12-1.27); the incremental cost ranged between 10 and 9 Euros. Participation in FIT screening (N. = 23,543) was increased only with simple pre-notification (B vs A - RR: 1.06, 95% CI: 1.02-1.10); the incremental cost was 22.5 Euros. GP consultation rate was not increased in group C. Conclusions: An advance notification represents a cost-effective strategy to increase participation in FS screening; its impact on the response to FIT screening was limited.

KW - CRC screening

KW - FIT

KW - Participation

KW - Sigmoidoscopy

UR - http://www.scopus.com/inward/record.url?scp=84922581960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922581960&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2015.01.005

DO - 10.1016/j.ypmed.2015.01.005

M3 - Article

C2 - 25602908

AN - SCOPUS:84922581960

VL - 73

SP - 106

EP - 111

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -